Martin Shkreli’s former company to pay $40M in settlement over drug price hikes
Shkreli became a symbol of pharmaceutical greed after his company, formerly Turing Pharmaceuticals, bought Daraprim in 2015 and then raised the price to $750 a tablet...
Continue Reading →
